Stockscreener 앱 받기
2.25
5.86%
-0.14
시간 외 거래:
2.15
-0.10
-4.44%
Gri Bio Inc 주식(GRI)의 최신 뉴스
GRI Bio: Positive phase 2A IPF results and IND plans for lupus program signal strong pipeline momentum - TradingView
GRI Bio: Positive phase 2A IPF data and pipeline progress position GRI Bio for key upcoming milestones - TradingView
Levels Update: Is now the right time to enter SHF Holdings IncPortfolio Value Report & Verified Momentum Stock Watchlist - baoquankhu1.vn
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Yahoo Finance
GRI Bio reports $8.2 million cash position, extends runway into Q1 2027 - Investing.com Canada
GRI Bio sees cash runway into 1Q27 - TipRanks
GRI Bio raises $14.5 mln to fund operations into Q1 2027 - TradingView
GRI Bio: Strong cash position and positive clinical data support continued pipeline advancement - TradingView
GRI Bio, Inc. Reports Strong Cash Position and Positive Phase 2a Results for GRI-0621 in Pulmonary Fibrosis - Quiver Quantitative
GRI Bio Reiterates Full Year 2025 Financial Results, - GlobeNewswire
GRI Bio (GRI) Price Target Increased by 2,700.00% to 656.88 - Nasdaq
Jobs Data: Will Predictive Oncology Inc benefit from rising consumer demandPortfolio Performance Report & Comprehensive Market Scan Insights - baoquankhu1.vn
Dip Buying: Is CALX forming bullish engulfing patternsForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aug Summary: What makes GRI Bio Inc stock attractive todayJuly 2025 Rallies & Low Drawdown Trading Techniques - baoquankhu1.vn
Trading Recap: Can OACCU deliver consistent dividendsJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Gri Bio Warns of Ongoing Internal Control Weaknesses That Could Threaten Financial Reporting Reliability and Investor Confidence - TipRanks
Rate Cut: Is GRI Bio Inc forming a double bottomQuarterly Portfolio Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Buyback Watch: Is JVSPAC Acquisition Corp Equity Right a momentum stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
GRI Bio: 2025 net loss rose to $12M as R&D spending increased; more capital needed for future trials - TradingView
GRI Bio, Inc. SEC 10-K Report - TradingView
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio May Offer Up To $250 Million In SecuritiesSEC Filing - TradingView
Movement Recap: Can GRI Bio Inc be recession proof2025 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn
GRI Bio (GRI) expands at-the-market equity program to $60M capacity - Stock Titan
GRI Bio reports positive gene expression data for IPF drug candidate - Investing.com Nigeria
What’s the RSI of GRI Bio Inc. stockQuarterly Portfolio Review & AI Forecasted Stock Moves - mfd.ru
GRI Bio delivers additional data from Phase 2a study of GRI-0621 - TipRanks
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened? - Asianet Newsable
GRI Bio Reports New Phase 2a Gene Expression Data Supporting Anti-Fibrotic Activity Of GRI-0621 - Nasdaq
GRI Bio reports promising Phase 2a data in IPF - TipRanks
GRI Bio stock soars after gene data shows IPF drug targets disease drivers - Investing.com Nigeria
GRI Bio stock soars after gene data shows IPF drug targets disease drivers By Investing.com - Investing.com South Africa
GRI Bio, Inc. Announces Positive Phase 2a Clinical Trial Data for GRI-0621 - TradingView
GRI Bio, Inc. Reports Positive Phase 2a Results for GRI-0621 as Disease-Modifying Therapy in Idiopathic Pulmonary Fibrosis - Quiver Quantitative
Early lung fibrosis trial hints drug may help repair damaged lung tissue - stocktitan.net
Market Leaders: Can Docebo Inc weather a recessionWeekly Trade Summary & Consistent Income Trade Recommendations - baoquankhu1.vn
GRI Bio secures U.S. composition of matter patent - TipRanks
GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures - GlobeNewswire
Trade Recap: Is DB Gold Double Short ETN stock a buy or sellTrade Signal Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
Analysis Recap: Can Viavi Solutions Inc withstand a market correction2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
Trade Report: Is GRI Bio Inc in a long term uptrendNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
GRI Bio To Carry Out 1-for-28 Reverse Stock Split On January 26th, 2026 - 富途牛牛
GRI Bio announces 1-for-28 reverse stock split to regain Nasdaq compliance - Investing.com Nigeria
GRI Bio stock falls after announcing 1-for-28 reverse split - Investing.com India
GRI Bio Announces Reverse Stock Split To Regain Minimum Bid Price Nasdaq Compliance - Nasdaq
Gri Bio Announces Reverse Stock Split - TradingView
GRI Bio Announces 1-for-28 Reverse Stock Split - TipRanks
GRI Bio stock falls after announcing 1-for-28 reverse split By Investing.com - Investing.com South Africa
GRI Bio (NASDAQ: GRI) plans 1-for-28 reverse stock split in January - stocktitan.net
GRI Bio slashes share count with 1-for-28 split to meet Nasdaq price rule - Stock Titan
GRI Bio Announces Reverse Stock Split - marketscreener.com
1.24%
0.19%
자본화:
|
볼륨(24시간):